Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuriaPiero Ruggenenti, Giuseppe Remuzzi, Maurizio Salvadori et al.|The Lancet|1999Cited by 909
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J.L. Heerspink, Tom Greene, Hocine Tighiouart et al.|The Lancet Diabetes & Endocrinology|2019Cited by 372
miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor CellsFabio Sallustio, Francesco Paolo Schena|PLoS ONE|2013Cited by 51